Tweets
Erosive #handOA is associated with more pain and more functional impairment than #RA - 10 year duration, which ofcourse has more comorbidities. 138 OA, 379 RA pts. #EULAR2023 @rheumnow abst#POS0103 https://t.co/mP3Nzgmw07
Bella Mehta @bella_mehta ( View Tweet )
3 years 1 month ago
Lots of early pipeline data in lupus at #EULAR2023 mainly in the supplement!
AFIMETORAN dual TLR7/8 ANTAGONIST in lupus mice! Maybe steroid sparing! Abst#AB0132
@RheumNow
Bella Mehta @bella_mehta ( View Tweet )
3 years 1 month ago
#lupus Phase 1 data #EULAR2023 humanised, afucosyl IgG1 antibody against CXCR5 – receptor on B cells and bonafide T follicular helper(Tfh) and circulating T follicular helper-like(cTfh) cells – Potent, tolerated and caused depletion of cells in SLE and RA.
Abst#AB0511 @rheumnow
Bella Mehta @bella_mehta ( View Tweet )
3 years 1 month ago
bone complications #SLE – imp to maintain vitamin D levels!
Osteonecrosis of the femoral head (ONFH) and Avascular osteonecrosis (AVN) – total 86 pts – 60 had both ONFN and AVN.
ONFN often b/l more morbidity, raynauds and low vit D compared to AVN
Abst#AB0566#EULAR2023 @rheumnow
Bella Mehta @bella_mehta ( View Tweet )
3 years 1 month ago
Obesity in #AOSD – predicted the development of a chronic disease course and biologic DMARD failure, 139 pts with AOSD- 19% Obese (BMI>30) observational study. abst#AB1503 #EULAR2023 @rheumnow
Bella Mehta @bella_mehta ( View Tweet )
3 years 1 month ago
Pearls in AOSD – from #EULAR2023 Italian study of 64 patients – AOSD/sJIA pts who achieved drug-free remission more often had white blood cells count >15.000/uL at baseline, however those who were treated with cyclosporine likely failed drug free remission. Abst#AB1484 @rheumnow
Bella Mehta @bella_mehta ( View Tweet )
3 years 1 month ago
Overview of treatment strategies in #Lupus #EULAR2023 #Rheumtwitter https://t.co/zL1nEDajsb
Christian Ammitzbøll @RheumTweeter ( View Tweet )
3 years 1 month ago
RheumNow’s expanded coverage of the #EULAR2023 meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
RheumNow Eular 2023 Daily Recap Series https://t.co/oZXuyv8wL5
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
75 different biosimilars in Europe, and nearly 20 years since the journey started. @EMA_News has led the world on biosimilars #EULAR2023 @RheumNow https://t.co/LFs3FR9dfW
David Liew @drdavidliew ( View Tweet )
3 years 1 month ago
Would you rather have Erosive hands OA or RA?
130+ EHOA and 370+ RA, dis duration > 10 yrs for both cohorts
📍EHOA associated w/ > pain & functional impairment
📍RA associated w/ > comorbidities
@RheumNow #EULAR23 POS0103 https://t.co/KdDG7E6PZw
Aurelie Najm @AurelieRheumo ( View Tweet )
3 years 1 month ago
A model predicts development of PsA in PSO cohort at 1 yr w/ AUC 72.3
Risk factors:
✔️younger age
✔️male
✔️family hx of PSO
✔️back stiffness
✔️nail pitting,
✔️stiffness
✔️PGA
✔️bioDMARDs
5yr prediction model AUC 75
Promising but to be confirmed
@RheumNow #EULAR23 POS0019 https://t.co/boCYOH2sDS
Aurelie Najm @AurelieRheumo ( View Tweet )
3 years 1 month ago
